Source: StreetInsider

Press Release: Affini-T : Affini-T Therapeutics to Present Data From Its Preclinical Programs Targeting KRAS G12D and TP53 R175H at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

BOSTON--(BUSINESS...

Read full article »
Affini-T's Competitors | Affini-T's News | Affini-T's Financials
Stay up-to-date with the latest news on Affini-T
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Jak Knowles's photo - Co-Founder & CEO of Affini-T

Co-Founder & CEO

Jak Knowles

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Affini-T